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Background: The induction of cellular defensive genes such as phase II detoxifying and antioxidant en-
zymes is a highly effective strategy for protection against carcinogenesis as well as slowing cancer
development. Transcription factor Nrf2 (nuclear factor E2-related factor 2) is responsible for activation of
phase II enzymes induced by natural chemopreventive compounds.
Methods: Red ginseng oil (RGO) was extracted using a supercritical CO2 extraction system and chemical
proﬁle of RGO was investigated by GC/MS. Effects of RGO on regulation of the Nrf2/antioxidant response
element (ARE) pathway were determined by AREeluciferase assay, western blotting, and confocal
microscopy.
Results: The predominant components of RGO were 9,12-octadecadienoic acid (31.48%), bicyclo[10.1.0]
tridec-1-ene (22.54%), and 22,23-dihydrostigmasterol (16.90%). RGO treatment signiﬁcantly increased
nuclear translocation of Nrf2 as well as ARE reporter gene activity, leading to upregulation of heme
oxygenase-1 and NAD(P)H:quinone oxidoreductase 1. Phosphorylation of the upstream kinases such as
apoptosis signal-regulating kinase (ASK)1, mitogen-activated protein kinase (MAPK) kinase (MKK)4/7, c-
Jun N-terminal kinase (JNK), and p38 MAPK were enhanced by treatment with RGO. In addition, RGO-
mediated Nrf2 expression and nuclear translocation was attenuated by JNK inhibitor SP600125 and
p38 MAPK inhibitor SB202190.
Conclusion: RGO could be used as a potential chemopreventive agent, possibly by induction of Nrf2/ARE-
mediated phase II enzymes via ASK1eMKK4/7eJNK and p38 MAPK signaling pathways.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Carcinogenesis is a multistep process including initiation, pro-
motion, and progression, in which the accumulation of genetic al-
terations leads to transformation of an initiated cell into a
population of preneoplastic cells and eventually a tumor with
invasive and metastatic capacities [1]. Recently, many dietary
phytochemicals have exhibited beneﬁcial effects on healthife Sciences, College of Biomedical
ce and Nutrition, Dong-A Universit
), mjun@dau.ac.kr (M. Jun).
ht  2016, The Korean Society of G
d/4.0/).including prevention, delay, and inhibition of cancer progression
[2]. Cancer chemoprevention is deﬁned as the use of natural, syn-
thetic, or biological chemical agents to prevent the early precan-
cerous stage of carcinogenesis [3]. Among the underlying
mechanisms of chemopreventive agents is the induction of phase II
detoxifying/antioxidant enzymes involved in carcinogen detoxiﬁ-
cation, and antioxidants, such as heme oxygenase (HO)-1, NAD(P)
H:quinone oxidoreductase (NQO)1, aldoeketo reductase (AKR), andScience and Engineering, Inje University, 197 Inje-ro, Gimhae 50834, Korea.
y, 550-37 Nakdongdae-ro, Saha-gu, Busan 49315, Korea.
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transcription factor Nrf2 (nuclear factor-E2-related factor 2) is
involved in the regulation of phase II enzymes through the acti-
vation of antioxidant response element (ARE), which is located in
the promoter region genes encoding these enzymes [4e6]. Under
physiological conditions, Nrf2 is sequestered in the cytoplasm by
binding to Keap1 (Kelch-like ECH-associated protein 1, cytosolic
repressor). Upon stimulations, however, Nrf2 dissociates from
Keap1 and translocates into the nucleus where it binds to ARE to
transcriptionally induce defensive genes [7,8]. Studies of Nrf2-
deﬁcient mice have highlighted the importance of phase II detox-
ifying/antioxidant enzymes in the deactivation of chemical car-
cinogens, as these mice were more susceptible to carcinogenesis
than normal mice were [9,10].
Many studies have demonstrated that activation of the Nrf2/ARE
pathway is related to the upstream kinases, including mitogen-
activated protein kinases (MAPKs), protein kinase C, phosphatidy-
linositol 3-kinase (PI3K), or transmembrane kinase [11]. MAPK
families, including c-Jun N-terminal kinase (JNK), extracellular
signal-regulating kinases (ERKs) and p38 MAPK are key signaling
molecules that respond to mitogenic stimulation or environmental
stress, resulting in expression of target proteins [12]. Speciﬁc MAPK
inhibitors have been shown to block the induction Nrf2 as well as
phase II detoxifying/antioxidant enzymes [13,14]. MAPKs are
regulated by their upstream kinases: ERK is activated by MAPK
kinase kinase (MKK)1 and MKK2, JNK by MKK4 and MKK7, and p38
MAPK kinase by MKK3, MKK4, and MKK6, which are activated by
upstream MAPK kinase kinases (MAPKKKs) [15,16].
Ginseng (Panax ginsengMeyer) is a representative herbal, which
has been widely used in Korea, China, and Japan for about 2,000
years. Red ginseng is made by steaming and drying fresh ginseng, a
process that chemically transforms components and acquires spe-
cial physiological activities such as antioxidant [17], antidiabetic
[18], antiobesity [19], and anticarcinogenic [20] effects. Although
several pharmacological effects of red ginseng have been studied,
they are mostly water-soluble fractions. Moreover, the biological
activities and molecular mechanisms of lipid-soluble moieties of
red ginseng have been poorly characterized. Lipophilic fractions
from red ginseng extracted with hydrophobic organic solvents such
as petroleum ether and hexane have been shown to have antith-
rombotic and antitumor effects [21,22]. Our group has recently
reported anti-inﬂammatory and hepatoprotective mechanisms of
supercritical CO2-extracted red ginseng oil (RGO) in vitro and in vivo
[23,24]. In addition, our previous study has demonstrated the
safety of RGO in an acute toxicity study using male and female
SpragueeDawley rats [25].
In the present study, we examined the chemical proﬁle of su-
percritical CO2-extracted RGO and its underlying mechanisms in
the induction of cellular defense system in HepG2 cells.
2. Materials and methods
2.1. Chemicals
Primary antibodies against Nrf2, NQO1, b-actin, and Lamin B
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA); HO-1, phospho (p)-ERK1/2, p-JNK, p-p38, p-Akt, p-MAPK/
ERK kinase (MEK)1/2, p-MKK3/MKK6, p-B-Raf, mixed lineage
protein kinase (MLK)3, stress-activated protein kinase/ERK kinase-
1 (SEK1)/MKK4, p-MKK7, phospho-apoptosis signal-regulating ki-
nase (p-ASK)1, and phospho-transforming growth factor b-acti-
vated kinase (p-TAK1) antibodies were purchased from Cell
Signaling Technology (Boston, MA, USA). Peroxidase-conjugated
secondary anti-rabbit and anti-goat antibodies were purchased
from Santa Cruz Biotechnology, and Alexa-Fluor-555-conjugatedsecondary antibody was from Cell Signaling Technology (Boston,
MA, USA). Speciﬁc inhibitors including U0126 (MEK1/2 inhibitor),
SP600126 (JNK inhibitor), SB202190 (p38 MAPK inhibitor), and
LY294002 (PI3 kinase inhibitor) were obtained from Cell Signaling
Technology. Triton X-100, polyethylene glycol and other chemicals
were from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Preparation of RGO
RGO was prepared as previously described [24]. Dried red
ginseng powder was placed into the extraction vessel of a pilot-
scale supercritical ﬂuid extraction system (Ilshin Autoclave Co.
Ltd., Daejeon, Korea). Extractions with supercritical CO2 were
operated at 6,500 psi (relative to 450 bar) in combination with
temperature at 65C. Extracted constituents were collected in a vial
that was preﬁlled with a trapping solvent and maintained at 4C
during the extraction step.
2.3. GC/MS
Analysis of RGO was performed using an HP-5MS capillary col-
umn (30 m 0.25 mm, 0.25 mm; Agilent Technologies, Santa Clara,
CA, USA) in a Gas chromatographyemass spectrometry (GC/MS)
(5,975C; Agilent Technologies). Samples were injected into the
column and run using split mode (split ratio¼ 10:1). The helium
carrier gas was programmed to maintain a constant ﬂow rate of
1 mL/min. Oven temperature was initially 80C for 3 min and then
ﬁnally raised to 300C at 4C/min. Compounds were tentatively
identiﬁed by comparingmass spectra of the peaks with those in the
mass spectrum library of NIST 11.
2.4. Cell culture
Human hepatoma HepG2 cell line was purchased from Amer-
ican Type Culture Collection (Manassas, VA, USA). HepG2-C8 cell
line was established by the stable transfection of HepG2 cells with
p-ARE-T1-luciferase reporter gene as previously described [26].
Both cell lines were maintained in F-12 medium with 10% fetal
bovine serum, 100 U/mL penicillin, 100 mg/mL streptomycin, 1%
essential amino acids, 1% GlutaMAX, and 0.1% insulin. The cells
were maintained in a humidiﬁed incubator at 37C in 5% CO2.
2.5. Cell viability assay
HepG2 cells were plated at 105 cells/well in 24-well plates and
treated with vehicle (polyethylene glycol: dimethyl sulfoxide, 1:1,
v/v) or various concentrations of RGO for 24 h. After incubation,
each well was washed twice with phosphate-buffered saline (PBS)
followed by incubation with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) for 4 h at 37C. Dark blue
formazan crystals were dissolved with dimethyl sulfoxide and
absorbance was measured with a PowerWave XS microplate reader
(BioTek Instruments, Inc., Winooski, VT, USA) at 570 nm. The per-
centage of viable cells was estimated by comparison with vehicle-
treated control cells.
2.6. AREeluciferase activity assay
HepG2-C8 cells were plated at 106 cells/well in 12-well plates
and incubated for 24 h. After starvation overnight, cells were
treated with RGO for 12 h, washed twice with PBS, and lysed with
the reporter lysis buffer supplied for luciferase assay system
(Promega, Madison, WI, USA). After centrifugation at 3,000 g for
10 min, a 10-mL aliquot of the supernatant was assayed for lucif-
erase activity with a GloMax luminometer (Promega). The
Table 1
Chemical composition of red ginseng oil analyzed by GC/MS
Retention
time
Compound Molecular
formula
Peak area
(%)
Acids
26.98 Palmitic acid C16H32O2 2.89
29.23 Linoleic acid C18H32O2 31.48
Alcohols
44.36 Ergosta-4,6,22-trien-3.alpha.-ol C28H44O 4.53
45.00 a-tocopherol C29H50O2 1.01
46.54 Stigmasterol C29H48O 3.14
47.27 b-sitosterol C29H50O 16.90
47.64 g-sitosterol C29H50O 4.31
Hydrocarbons
35.79 Likely bicyclo[10.1.0]tridec-1-ene C13H22 22.54
43.22 Stigmastan-3,5-diene C29H48 0.60
46.87 Tritetracontane C43H88 0.93
Others
49.05 Stigmast-4-en-3-one C29H48O 1.01
M.J. Bak et al / Cytoprotective gene induction by red ginseng oil 425luciferase activity was normalized against protein concentration,
determined using a BCA protein assay (Pierce Biotechnology,
Rockford, IL, USA), and expressed as fold of induction over lucif-
erase activity of vehicle-treated control cells.
2.7. Preparation of whole-cell, nuclear and cytosolic extracts
Whole-cell extract was prepared using cell lysis buffer con-
taining 20mM Tris (pH 7.5), 135mM sodium chloride, 2mM EDTA,
2mM dithiothreitol, 25mM b-glycerophosphate, 2mM sodium py-
rophosphate, 10% glycerol, 1% Triton X-100, 1mM sodium orthova-
nadate, 10mM sodium ﬂuoride, 10 mg/mL aprotinin, 10 mg/mL
leupeptin, and 1mM phenylmethanesulfonyl ﬂuoride. Nucleare
cytoplasmic fractionationwas conducted using NE-PER Nuclear and
Cytoplasmic Extraction Reagents Kit (Pierce Biotechnology), and
protein concentrations were determined by BCA protein assay.
2.8. Western blotting
Proteins (whole-cell extracts: 30 mg/lane, nuclear extracts: 10 mg/
lane, and cytosolic extracts: 30 mg/lane) were separated on 10% so-
dium dodecyl sulfate polyacrylamide gels. The separated proteins
were electrophoretically transferred onto polyvinylidene ﬂuoride
membranes (Millipore, Billerica, MA, USA) with a semidry transfer
system(Bio-Rad,Hercules, CA,USA). Themembraneswere incubated
with blocking solution (5% nonfat milk) for 1 h, and then incubated
overnight with proper primary antibodies. After hybridization with
primary antibodies, the membranes were washed three times with
PBS/Tween 20 (PBST) solution and incubated with horseradish-
peroxidase-conjugated secondary antibodies for 1 h. The mem-
braneswere againwashed three timeswith PBST, and detected using
Western Blotting Luminol reagents (Santa Cruz Biotechnology).
2.9. Confocal microscopy
Cellswere cultured in coverglass-bottomdishes. After starvation,
the cells were pretreated with speciﬁc inhibitors for 1 h and then
with RGO for 2 h. The cells were ﬁxed with 4% paraformaldehyde in
PBS for 10min and permeabilizedwith 0.3% Triton X-100 for 10min.
After incubation with blocking buffer (3% bovine serum albumin in
PBS) for 1 h, cells were incubatedwith Nrf2 antibody (1:100) in 0.3%
bovine serum albumin for 2 h. The cells were stained for 2 h with
Alexa-Fluor-555-conjugated secondary antibody (1:200) in the
dark, and ﬁnally incubated with 1 mg/mL of 40,60-diamidino-2-
phenylindole for 20 min in the dark. Images were obtained using a
LSM 510 laser confocal microscope (Zeiss, Jena, Germany).
2.10. Statistical analysis
The data were expressed as mean standard deviation values
by Microsoft Excel 2010 software (Microsoft Corporation, Red-
mond, WA, USA). The values were compared with the control using
analysis of variance followed by unpaired Student t tests. A value of
p< 0.05 was considered signiﬁcant.
3. Results
3.1. Chemical composition of RGO
Chemical composition of the supercritical CO2-extracted RGO
was analyzed for the ﬁrst time using GC/MS (Table 1). The identiﬁed
compounds were composed of three major groups including acids
(34.37%), alcohols (29.89%), and hydrocarbons (24.07%). RGO con-
tained fatty acids including linoleic acid (C18:2, 31.48%), and pal-
mitic acid (C16:0, 2.89%). Ginseng seed oil has been reported tohave oleic acid (C18:1) as the most predominant fatty acid (80%)
followed by linoleic acid (16%) and palmitic acid (2%) [27]. Unlike
ginseng seed oil, oleic acid was not detected and linoleic acid was
themost predominant fatty acid in RGO. A previous study analyzing
fatty acid composition of a lipophilic fraction from red ginseng
extracted with petroleum ether has shown that linoleic accounts
for about 75% of fatty acids in the fraction followed by palmitic acid
(10%) [22], which corresponds to our results. For alcohols, b-sitos-
terol was the most abundant (16.90%) in RGO while ergosta-4,6,22-
trien-3a-ol (4.53%), g-sitosterol (4.31%), stigmasterol (3.14%), stig-
masterol, and a-tocopherol (1.01%) were also detected. Stigmasterol
and b-sitosterol have been previously found in ginseng seed oil
[27]. A hydrocarbon bicyclo(10.1.0)tridec-1-ene was detected with
a signiﬁcant amount (22.54%) in RGO. This compound has been
found in the fruit of an Iranian berry (Bereberise integrrima) [28]
and the essential oil from buds of Tussilago farfara L [29]. Three
compounds including linoleic acid, bicyclo(10.1.0)tridec-1-ene, and
b-sitosterol occupied nearly 71% of RGO.
3.2. Effect of RGO on cell viability
Hepatocytes play a crucial role in the processes of metabolism,
detoxiﬁcation, modiﬁcation, and excretion of exogenous and
endogenous substances, implying that it is a target for the toxic
action of xenobiotics or their reactive metabolites [30]. Enhance-
ment of cellular defense system importantly contributes to pro-
tection of cells/tissues from damage caused by toxicants or
oxidative stress. Consequently, HepG2 human hepatoma cell line is
considered as a good model for studying the inductive effect of
natural products on phase II detoxifying/antioxidant enzymes,
which directly involve in cytoprotective action [31]. In the present
study, the viability of HepG2 cells was determined to evaluate the
cytotoxic effect of RGO using MTT assay. RGO treatment for 24 h
resulted in a decrease of cell viability in a dose-dependent manner
(Fig. 1). The treatment of HepG2 cells with 50 mg/mL RGO was
unlikely to cause signiﬁcant cell death, and therefore, RGO con-
centrations < 50 mg/mL were selected for subsequent experiments
of activation of Nrf2/ARE-mediated cytoprotective genes.
3.3. Induction of phase II detoxifying/antioxidant enzymes by RGO
Phase II enzymes play important roles in the protection of cells/
tissues from endogenous and/or exogenous carcinogens [32].
Accordingly, we ﬁrst examined the inductive effect of RGO on the
phase II enzymes expression after 24 h treatment. The protein
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Fig. 1. Effect of RGO on cell viability in HepG2 cells. Cells were treated with vehicle
(dimethyl sulfoxide: polyethylene glycol, 1:1, v/v, 0.1%) or RGO at the indicated con-
centrations for 24 h. Cell viability was assessed with MTT assay. Data represent the
average SD of three independent experiments with similar results. * p< 0.05
compared to the vehicle-treated control. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; RGO, red ginseng oil.
J Ginseng Res 2016;40:423e430426expression levels of HO-1 and NQO1 signiﬁcantly and dose-
dependently increased in RGO-treated HepG2 cells (Fig. 2). RGO
treatment at the concentration of 50 mg/mL elevated protein levels
of HO-1 and NQO1 by 160% and 200%, respectively, compared to
untreated controls. Similarly, expression of HO-1 and NQO1 was
strongly induced in the treatment of sulforaphane (SFN), a known
phase II genes activator.
3.4. Induction of Nrf2/ARE machinery by RGO
To investigate whether the induction of phase II detoxifying/
antioxidant enzymes by RGO was associated with the activation of
Nrf2/ARE pathway, we examined the ARE luciferase activity andHO-1
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Fig. 2. Effect of RGO on NAD(P)H:quinone oxidoreductase and heme oxygenase-1 protein
ethylene glycol, 1:1, v/v, 0.1%) or RGO for 12 h and then an equal amount of proteins from w
control. The ratio of immunointensity between the target genes and b-actin was calculated
similar results. * p< 0.05 compared to the vehicle-treated control. RG, red ginseng oil.Nrf2 activation in RGO-treated HepG2-C8 and HepG2 cells,
respectively. As shown in Fig. 3A, RGO signiﬁcantly enhanced ARE
luciferase activity in a dose-dependent manner and RGO at 50 mg/
mL exerted greater induction than SFN; a potent natural inducer of
Nrf2/ARE pathway [33]. ARE is a crucial regulatory element found
in the promoter region of many cellular defensive genes encoding
phase II detoxifying and/or antioxidant enzymes including NQO1
and HO-1 [5], suggesting that the induction of phase II enzymes by
RGO could be mediated by the transcriptional activation of ARE.
Based on the potent inductive ability of RGO on the ARE tran-
scriptional activity, the effect of RGO on Nrf2 protein expression
and its nuclear translocation was analyzed. Similar to luciferase
activity, RGO upregulated protein expression of Nrf2 in a dose-
dependent manner (Fig. 3B). In addition, the level of Nrf2 protein
in the nucleus was gradually elevated with the dose of RGO,
whereas protein level of Nrf2 in the cytoplasm decreased (Fig. 3C).
Nuclear accumulation of Nrf2 was enhanced approximately 230%
by RGO treatment at 50 mg/mL compared with vehicle-treated
controls. These ﬁndings indicate that the nuclear translocation of
Nrf2 by RGO might facilitate the transcriptional activation of ARE-
dependent genes.
3.5. Regulation of HO-1 and NQO1 expression by RGO through ASK-
MKK4/7-JNK and p38 MAPK signaling pathways in HepG2 cells
To analyze the underlying mechanisms responsible for RGO-
induced phase II enzymes, HepG2 cells were treated with RGO for
1 h and induction of upstream kinase Akt and MAPKs including
ERK, JNK and p38 MAPK was determined. As shown in Fig. 4, RGO
dose-dependently stimulated phosphorylation of Akt and all three
MAPKs. To further address the role of individual Akt and MAPK
pathways in RGO-induced Nrf2 expression, speciﬁc kinase in-
hibitors (U0126 for MEK1/2, SB202190 for p38 MAPK, SP600125 for
JNK, and LY294002 for Akt) were pretreated for 1 h prior to RGO
treatment. The result showed that RGO-induced Nrf2 expression
was markedly blocked by JNK inhibitor (SP600125) and           50            25
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Fig. 3. Effect of RGO on antioxidant response element-reporter gene activity, Nrf2 protein expression, and nuclear translocation in HepG2 cells. (A) HepG2-C8 cells, stably
transfected with pARE-T1-luciferase reporter gene, were treated with vehicle (DMSO: PEG, 1:1, v/v, 0.1%) or RGO for 12 h. Luciferase activity was normalized with protein content
and expressed as fold induction against vehicle-treated control. (B) Nrf2 expression. Cells were treated with vehicle (DMSO: PEG, 1:1, v/v, 0.1%) or RGO for 2 h and then an equal
amount of protein from whole cell lysates was analyzed by western blotting. (C) Levels of Nrf2 in nuclear and cytoplasmic extracts from HepG2 cells treated with RGO for 2 h were
evaluated using western blot analysis. Sulforaphane was used as a positive control. The ratio of immunointensity between Nrf2 and b-actin was calculated. Data represent the
mean standard deviation of three independent experiments with similar results. * p< 0.05 compared to the vehicle-treated control. DMSO, dimethyl sulfoxide; Nrf2, nuclear
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and LY294002 were unlikely to diminish Nrf2 expression level
(Fig. 5A). Furthermore, the RGO-mediated nuclear translocation of
Nrf2was signiﬁcantly inhibited by SP600125 and SB202190, but not
by U0126 or LY294002 (Fig. 5B). These results suggest that RGO-
mediated Nrf2 induction is regulated through JNK and p38 MAPK
signal transduction pathways. Activation of MAPKs requires tyro-
sine and threonine phosphorylation by activatedMAPKKs (MEK1/2,
SEK1/MKK4, MKK7, and MKK3/6). Among the MAPKs, the activa-
tion of JNK is catalyzed by two upstream kinases, MKK4 and MKK7
[16,34]. The activation of MKK4 and MKK7 is mediated by
MAPKKKs including MLKs, ASKs, and dual leucine zipper kinases
[35,36]. To further investigate the upstream kinases of JNK and p38
MAPK, we examined the regulatory role of RGO in the phosphor-
ylation of MAPKKs (MKK3/6, MEK1/2, MKK4, and MKK7) and
MAPKKKs (TAK1, B-Raf, ASK1, and MLK3). RGO-treated HepG2 cells
resulted in the increased phosphorylation levels of MKK4/7 and
ASK1, whereas RGO was unlikely to exhibit a signiﬁcant effect on
phosphorylation of MLK3, TAK1, and MKK3/6, implying that RGO
directly regulated p38 MAPK phosphorylation without affecting
upstream kinases including MKK3/6 and MLK3/TAK1 (Fig. 6). Our
ﬁndings reveal that the RGO-induced expression of phase IIenzymes could be regulated by Nrf2/ARE machinery through acti-
vation of ASK1eMKK4/7eJNK and p38 MAPK signaling trans-
duction pathways.
4. Discussion
Consumption of natural products is one of the crucial strategies
to prevent the risk of many diseases such as cardiovascular dis-
eases, diabetes, and cancer. This could be achieved through
inductive effects of chemopreventive phytochemicals on cellular
defense systems, including phase II detoxifying and antioxidant
enzymes to eliminate chemical carcinogens and oxidative stress. In
the present study, we analyzed the chemical constituents and
investigated the chemopreventive properties of RGO. The results
demonstrated that RGO induces Nrf2 nuclear translocation and
phase II enzymes, including HO-1 and NQO1, through activation of
ASK1eMKK4/7eJNK and p38 MAPK signaling pathways in HepG2
cells.
GC/MS analysis revealed that RGO contains many bioactive
compounds, in which linoleic acid, b-sitosterol, and bicyclo(10.1.0)
tridec-1-ene are major components accounting for about 70% of
RGO. Recently, many ﬁndings have demonstrated the bioactivities
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was signiﬁcantly different from the vehicle-treated control. RGO, red ginseng oil.
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Fig. 5. Effect of speciﬁc inhibitor of mitogen-activated protein kinase and Akt on RGO-induced Nrf2 protein expression and nuclear translocation in HepG2 cells. (A) Cells were
treated with speciﬁc inhibitor for MAPKERK kinase 1/2 (U0126, 50mM), C-Jun N-terminal kinase (SP600125, 50mM), p38 (SB202190, 50mM), and Akt (LY294002, 50mM) for 1 h
followed by incubation with RGO (50 mg/mL) for 2 h. Western blotting for protein expression of Nrf2. Data are expressed as means SD of three independent experiments. * p< 0.05
compared to the vehicle-treated control. ** p< 0.05 compared to the RGO-treated group. (B) Cells were ﬁxed and immunostained with anti-Nrf2 antibody, whereas the nucleus was
stained with 4’,6’-diamidino-2-phenylindole. The images of the cellular immunoﬂuorescence were acquired using an LSM 510 laser confocal microscope (Zeiss, Jena, Germany).
Nrf2, nuclear factor E2-related factor 2; RGO, red ginseng oil.
J Ginseng Res 2016;40:423e430428of linoleic acid and b-sitosterol; however, no study has yet reported
any biological characteristics of bicyclo(10.1.0)tridec-1-ene. Linoleic
acid has been demonstrated to be an inducer of Nrf2 in mouse
primary hepatocytes [37]. Our previous study showed thatsitosterol might induce cellular protective systems through acti-
vation of the Nrf2/ARE pathway in HepG2 cells [38]. In addition,
Zhang et al [39] have reported that phytosterins such as b-sitos-
terol, campesterol, and stigmasterol protected against 4-
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Fig. 6. Effect of RGO on the MAPKK and MAPKKK signaling pathways in HepG2 cells. (A) Effects of RGO on phosphorylation of MAPKK. HepG2 cells were treated with RGO at 50 mg/
mL for 30 min. (B) Effects of RGO on phosphorylation of MAPKKK. HepG2 cells were treated with RGO at 50 mg/mL for 15 min. Data are expressed as means SD of three inde-
pendent experiments. * p< 0.05 compared to the vehicle-treated control. MAPKK, mitogen-activated protein kinase kinase; MAPKKK, mitogen-activated protein kinase kinase
kinase; RGO, red ginseng oil.
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mediated detoxifying/antioxidant enzymes in rat testes. b-Sitos-
terol enhances antioxidant enzymes that contribute to the beneﬁ-
cial effects of olive oil consumption [40]. American ginseng oil may
be useful as a functional ingredient since it contains various kinds
of phytosterols, including squalene, campesterol, stigmasterol,
sitosterol, oxidosqualene, and avenasterol, which are considered to
promote human health by reducing cholesterol in humans [41].
It has been well documented that phase II enzymes could have
signiﬁcant effects on the prevention of tumor initiation through
preventing activation of procarcinogens to reactive intermediates
and increasing the neutralization of oxidative stress [32,42]. HO-1,
catalyzing the conversion of heme into biliverdin, free iron, and CO
[43], plays an important role in maintaining cellular redox ho-
meostasis against oxidative stress [44]. NQO1, a detoxifying
enzyme, catalyzes the two-electron reductive metabolism and
detoxiﬁcation of quinines and their derivatives, resulting in pro-
tection of cells from oxidative stress and cancer development
[45,46]. In the ﬁeld of cancer prevention, phytochemicals have been
attracting a lot of interest due to their abilities to induce phase II
detoxifying/antioxidant enzymes. A series of phytochemicals such
as Epigallocatechin gallate (EGCG), resveratrol, sulforaphane, and
quercitrin have been demonstrated as potent inducers of phase II
and antioxidant enzymes, including HO-1 and NQO1 [47e50]. Nrf2
is a key transcription factor in the transcriptional induction of
phase II detoxyfying/antioxidant enzymes, via ARE. An in vivo study
demonstrated that expression of phase II enzymes such as NQO1
and GSTA1 is markedly abrogated in nrf2-deﬁcient mice as
compared with wild-type animals [51]. Exposure of cells to Nrf2
inducers results in enhanced expression of many protective genes
[49,50,52]. Therefore, activation of Nrf2 contributes to regulation of
a powerful cluster of protective genes. One possible mechanism of
Nrf2 activation is post-transcriptional modiﬁcation of Nrf2 by
protein kinases, which increase its stability and subsequent tran-
scription activity. Protein kinases play a crucial role in converting
various extracellular signals into intracellular responses through
serial phosphorylation cascades. Phosphorylation of Nrf2 at serine
and threonine residues by protein kinases such as PI3K/Akt, ERK,
JNK, and p38 MAPK result in liberation of Nrf2 from Keap1 (Nrf2
inhibitor), enhancing Nrf2 nuclear accumulation, and ﬁnallytriggering transcriptional activation of phase II enzymes [7,8].
Phosphorylation is one of the key steps for activation of the Nrf2
pathway; however, the effect of individual protein kinases on Nrf2/
ARE signaling systems may depend on cell/tissue types as well as
inducers. Phenethyl isothiocyanate activates expression of Nrf2/
ARE-mediated phase II enzymes through a JNK1-dependent
pathway in HeLa cells [53], whereas p38 MAPK is involved in in-
duction of Nrf2-mediated cellular defense systems by quercitrin in
HepG2 cells [54]. Tea catechin EGCG-induced HO-1 expression and
Nrf2 nuclear accumulation have been shown through Akt and p38
MAPK signal transduction pathways [55].
In conclusion, the lipid-soluble constituents were determined in
RGO with three major compounds including linoleic acid, bicyclo
[10.1.0]tridec-1-ene, and b-sitosterol. Moreover, RGO potently
induced expression and nuclear translocation of the transcription
factor Nrf2, leading to transcriptional activation of ARE-mediated
phase II detoxifying/antioxidant enzymes, possibly via ASK1e
MKK4/7eJNK and p38 MAPK signaling transduction pathways in
HepG2 cells. Our results suggest that RGO might be a new potential
source of natural chemopreventive and cellular defensive agents.
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